Cite
HARVARD Citation
Schmidt, P. et al. (n.d.). Combination therapy with a Tmprss6 RNAi‐therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β‐thalassemia intermedia. American journal of hematology. 90 (4), pp. 310-313. [Online].